ERG and prostate carcinoma: In particular, in 2005, a chromosomal rearrangement leading to the fusion of the androgen-regulated gene TMPRSS2 and one of the ETS genes, predominantly ERG, was described as being expressed in 40–70% of prostate cancers (PCas) from a radical prostatectomy series [2].